RxDoctor Payments Data

Phong Vu, MD

Neurology · Morgantown, WVNPI 1659734952

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,363 of the $5,173 with a category attached, or 65.0%. It is spread thinly across 13 manufacturers, the largest accounting for just 22.8%. Reporting peaked in 2024 at $2,006 and has fallen 84.1% since, to $320 in 2025.

$5,173in general payments, 2019–2025

Across 88 payments — averaging $58.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microvention, Inc.$1K
  • Medical Device Business Services, Inc.$1K
  • Stryker$913
  • Johnson & Johnson$827
  • Route 92 Medical, Inc.$306
  • Microsurgical Technology, Inc.$242
  • plus $641 from 7 others

What the payments were for

  • Travel & lodging$1,76034%
  • Food & beverage$3,36365%
  • Education$501%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,173 in reported general payments places this provider in the 70th percentile of 93 neurology providers in West Virginia.

See all neurology providers in West Virginia

Medicare billing

Part B allowed, 2024
$47,425
Medicare patients
155
Services billed
304

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CopaxoneGlatiramer Acetate12$68,024
EliquisApixaban15$16,457
Donepezil Hcl142$1,981
Memantine Hcl65$1,402
Propranolol Hcl ErPropranolol Hcl38$1,149
Gabapentin104$1,068
Levetiracetam33$788
Carbidopa-LevodopaCarbidopa/Levodopa36$601
Modafinil15$459
RizatriptanRizatriptan Benzoate18$456
Primidone26$407
Phenytoin Sodium Extended15$340
Pregabalin25$287
Topiramate50$246
Meclizine Hcl22$241

Paid to pharmacies, not to this prescriber.

Other neurology in Morgantown

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →